Clinical Trial Update: Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes using arsenic trioxide to treat patients with recurrent or refractory acute leukemia, chronic myeloid leukemia, myelod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Drugs mentioned

• Trisenox (arsenic trioxide)

Snippet

Sponsor: Our Lady of Mercy Medical Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: UNKNOWN